SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Florida enthusiastically welcomes Calcalist conference to Miami

Bitsight acquires Cybersixgill in $115 million deal to strengthen cyber risk management

Full list of Israeli startup M&As in 2024

Immunai and Teva launch multi-tear AI collaboration for smarter drug development

Buzz

Most popular

Daily

Weekly

1

Oracle CEO: "If we continue on our current trajectory, reaching a valuation of a trillion dollars is inevitable"

2

Is your solitaire opponent actually a bot?

3

Cloudera acquires Israeli startup Octopai to advance metadata and AI integration

4

Former Snyk founder Guy Podjarny secures $125M for AI-powered software startup Tessl

5

CyberArk and Wiz join forces to enhance cloud security in multi-cloud environments

Fremanezumab

1 stories about Fremanezumab

אתר טבע כפר סבא

Teva Discontinues Development of Cluster Headache Drug

24.04.19|Tzally Greenberg

Under Teva’s brand name Ajovy, fremanezumab has already been approved in the U.S. and Europe as a preventative migraine treatment